TABLE 1.

Patients baseline characteristics (n = 42)

Characteristic
Age (years): median (range)	52 (25–90)
Performance status: median (range)	1 (0–2)
Gender: n (%)
Male	6 (14%)
Female	36 (86%)
Primary site: n (%)
Breast/chest wall	12 (29%)
Face/scalp	9 (21%)
Heart	8 (19%)
Other viscera	7 (17%)
Limbs	7 (17%)
Disease extent: n (%)
Locally advanced	10 (24%)
Metastatic	32 (76%)
Number of metastatic sites: median (range)	2 (1–4)
Previous systemic treatments in neoadjuvant and metastatic settings: n (%)
Anthracyclines	38 (90%)
Weekly Paclitaxel	38 (90%)
Ifosfamide	13 (31%)
Pazopanib	9 (21%)
Oral cyclophosphamide	6 (14%)
Dacarbazine	4 (10%)
Vinorelbine	4 (10%)